The controversial role of phospholipase C epsilon (PLCε) in cancer development and progression
Anna Tyutyunnykova, Г. Д. Телегеев, Anna Dubrovska · Journal of Cancer · 2017
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · review · 2017
Abstract
The phospholipase C (PLC) enzymes are important regulators of membrane phospholipid metabolism.PLC proteins can be activated by the receptor tyrosine kinases (RTK) or G-protein coupled receptors (GPCR) in response to the different extracellular stimuli including hormones and growth factors.Activated PLC enzymes hydrolyze phosphoinositides to increase the intracellular level of Ca 2+ and produce diacylglycerol, which are important mediators of the intracellular signaling transduction.PLC family includes 13 isozymes belonging to 6 subfamilies according to their domain structures and functions.Although importance of PLC enzymes for key cellular functions is well established, the PLC proteins belonging to the ε, ζ and η subfamilies were identified and characterized only during the last decade.As a largest known PLC protein, PLCε is involved in a variety of signaling pathways and controls different cellular properties.Nevertheless, its role in carcinogenesis remains elusive.The aim of this review is to provide a comprehensive and up-to-date overview of the experimental and clinical data about the role of PLCε in the development and progression of the different types of human and experimental tumors.
Open the resolved locator · 10.7150/jca.17779
Metadata licence: OpenAlex metadata (CC0)